1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Bladder cancer

Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy

Technology appraisal guidance [TA525] Published date: 13 June 2018

  • Guidance
  • Tools and resources
  • Information for the public
  • History

Documents

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 236.71 KB 13 June 2018  

Final appraisal determination

  • Final appraisal determination  
  • Committee papers PDF 1.01 MB 17 May 2018  
  • Public committee slides PDF 419.88 KB 17 May 2018  
  • Final appraisal determination document PDF 114.72 KB 17 May 2018  

Appraisal consultation

  • Appraisal consultation  
  • Appraisal consultation document PDF 384.4 KB 22 December 2017  
  • Public committee slides PDF 819.79 KB 22 December 2017  
  • Committee papers PDF 3.88 MB 22 December 2017  

Appraisal consultation: 1

  • Appraisal consultation: 1  
  • Committee papers PDF 16.21 MB 28 September 2017  
  • Public committee slides PDF 8.96 MB 28 September 2017  
  • Appraisal consultation document PDF 360.69 KB 28 September 2017  

Invitation to participate

  • Final scope PDF 54.63 KB 28 September 2017  
  • Final matrix PDF 176.78 KB 28 September 2017  
  • NICE's response to comments on the draft scope and provisional matrix PDF 210.48 KB 28 September 2017